Antagonists of the human A(2A) receptor have been reported to have potential therapeutic benefit in the alleviation of the symptoms associated with neurodegenerative movement disorders such as Parkinson's disease. As part of our efforts to discover potent and selective antagonists of this receptor, we herein describe the detailed optimization and structure-activity relationships of a series of pyrimidine-4-carboxamides. These optimized derivatives display desirable physiochemical and pharmacokinetic profiles, which have led to promising oral activity in clinically relevant models of Parkinson's disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmc.2009.07.078 | DOI Listing |
Publication Analysis
Top Keywords
antagonists human
8
human a2a
8
a2a receptor
8
parkinson's disease
8
receptor optimization
4
optimization pyrimidine-4-carboxamides
4
pyrimidine-4-carboxamides antagonists
4
receptor reported
4
reported potential
4
potential therapeutic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!